What is the recommended medication regimen for intubation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Medication Regimen for Intubation

For rapid sequence intubation in adults, administer etomidate 0.2-0.4 mg/kg (maximum 20 mg) as the induction agent followed immediately by succinylcholine 1-1.5 mg/kg as the neuromuscular blocking agent, or use rocuronium 1.0-1.2 mg/kg when succinylcholine is contraindicated. 1

Induction Agent Selection

First-Line: Etomidate

  • Etomidate 0.2-0.4 mg/kg IV (maximum 20 mg) is the preferred induction agent for most adult patients due to its hemodynamic stability and ability to lower intracranial pressure 2, 1
  • Provides optimal conditions for patients with head injury, multisystem trauma, or hypotension 2
  • Does not have analgesic properties and may cause brief myoclonic activity (hiccups, cough, twitching) 2
  • Causes transient adrenal suppression that is generally not clinically significant, though consideration should be given in septic patients 1

Alternative: Ketamine

  • Ketamine 1-2 mg/kg IV is the preferred alternative, particularly in hemodynamically unstable patients 2, 1
  • Provides sympathomimetic effects that help maintain blood pressure 1
  • Increasingly favored in critically ill patients due to cardiovascular stability 2
  • Critical caveat: Patients with depleted catecholamine stores (severe shock, chronic critical illness) may not benefit from ketamine's sympathomimetic effects and could experience hypotension 3

Third Option: Propofol

  • Propofol is a rapidly reversible agent that can be used when etomidate and ketamine are not suitable 2
  • Propofol carries higher risk of hypotension in critically ill patients and should be used cautiously 2
  • Doses of 2 mg/kg are typically used for induction 2

Neuromuscular Blocking Agent Selection

First-Line: Succinylcholine

  • Succinylcholine 1-1.5 mg/kg IV is the first-line paralytic for patients with respiratory or cardiovascular compromise 2, 1
  • Provides rapid onset and short duration of action 2
  • Absolute contraindications include: hyperkalemia, burns >24 hours old, crush injuries, prolonged immobilization, or neuromuscular disease due to risk of fatal hyperkalemic cardiac arrest 1

Alternative: Rocuronium

  • Rocuronium 1.0-1.2 mg/kg IV should be used when succinylcholine is contraindicated 2, 1, 4
  • The FDA-approved dose for rapid sequence intubation is 0.6-1.2 mg/kg 4
  • Doses of 0.9-1.2 mg/kg provide intubating conditions equivalent to succinylcholine at 60 seconds 2, 1
  • Research demonstrates that 1.04 mg/kg provides 95% probability of successful intubation at 60 seconds when combined with fentanyl and propofol 5
  • Sugammadex must be immediately available for potential reversal in "can't intubate, can't ventilate" scenarios 2, 1

Adjunctive Medications

Opioid Co-Induction

  • Fentanyl 1-2 mg/kg IV administered as an adjunct enables lower doses of hypnotics, promoting cardiovascular stability 2
  • Co-induction with rapidly-acting opioids minimizes intracranial pressure changes 2
  • Rapid administration of fentanyl can cause glottic and chest wall rigidity, even at doses as low as 1 mg/kg, so titrate slowly over several minutes unless a muscle relaxant is also being administered 2
  • Higher doses (1-5 mg/kg) are often recommended specifically for intubation 2

Pediatric Pretreatment

  • Atropine 0.01-0.02 mg/kg IV (maximum 0.5 mg) must be administered to children aged 28 days to 8 years before intubation 1
  • This is particularly important when using succinylcholine or in patients with septic shock or hypovolemia 1

Pediatric Dosing Modifications

  • Succinylcholine: 2 mg/kg IV for infants and small children; 1 mg/kg for older children/adolescents 1
  • Ketamine: 1-2 mg/kg IV (preferred in children) 1
  • Etomidate: 0.2-0.4 mg/kg IV for children >2 years (avoid in sepsis) 1
  • Rocuronium: 0.9-1.2 mg/kg IV when succinylcholine contraindicated 1
  • Rocuronium is not recommended for rapid sequence intubation in pediatric patients per FDA labeling 4

Critical Pitfalls to Avoid

Dosing Errors

  • Underdosing rocuronium (using 0.6 mg/kg instead of 1.0-1.2 mg/kg) significantly worsens intubating conditions and increases complications 6
  • The intubation model matters: true RSI (immediate administration after hypnotic) requires higher rocuronium doses than modified RSI 6
  • With thiopental induction, conventional rocuronium doses (0.6-0.7 mg/kg) provide significantly worse conditions than with propofol; high doses (0.9-1.2 mg/kg) are required 6

Medication Availability

  • Never use rocuronium without immediately available sugammadex, as prolonged paralysis creates dangerous situations if intubation fails 1
  • Ensure vasopressors are immediately available to manage potential hypotension during induction 3

Technique Without Muscle Relaxants

  • Avoiding neuromuscular blocking agents is associated with increased difficulty and complications in critically ill patients 2
  • If muscle relaxants must be avoided, remifentanil 4 mcg/kg with propofol 2 mg/kg can provide acceptable conditions, but this is not standard practice 7
  • Research shows that even with high-dose opioids (fentanyl 0.2 mg), intubation without muscle relaxants produces worse vocal cord conditions 8

Monitoring Requirements

  • Quantitative Train-of-Four (TOF) must be >90% before extubation 9
  • Peripheral nerve stimulator is recommended for determination of drug response and need for additional doses 4

References

Guideline

Rapid Sequence Intubation Medications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anesthetic Regimen Assessment for Intubation in Patients with Cardiovascular Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Laryngospasm Prevention and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.